NCT05324280 Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain
| NCT ID | NCT05324280 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Vulvodynia |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2022-06-23 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2022-06-23 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: Vulvodynia and chronic pelvic pain (CPP) are common and challenging gynecologic pain syndromes. A multidisciplinary approach is recommended. Study aim: To study the effectiveness of acupuncture as part of a multimodal treatment for women with vulvodynia and CPP. Design: Randomised controlled clinical study Study Population: Recruitment from a University outpatient clinic Study groups: Participants will be randomised (1:1) * Acupuncture group * Waiting list control group Sample size: 68 patients Study outcome * Subjective Pain Perception (VAS) * Health-related quality of life (questionnaires)
Eligibility Criteria
Inclusion Criteria: * Women with vulvodynia and/or chronic pelvic pain of at least 6 months duration * multidisciplinary treatment for at least 3 months Exclusion Criteria: * Pregnancy * Current malignancy * Major neurologic or psychiatric morbidity * Study participation in Lydia trial (Lasertherapy for vulvodynia)
Frequently Asked Questions
Who can join the NCT05324280 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Vulvodynia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05324280 currently recruiting?
Yes, NCT05324280 is actively recruiting participants. Visit ClinicalTrials.gov or contact Medical University of Graz to inquire about joining.
Where is the NCT05324280 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT05324280 clinical trial?
NCT05324280 is sponsored by Medical University of Graz. The trial plans to enroll 68 participants.